223 related articles for article (PubMed ID: 30006173)
21. Synthesis and anticancer activity of new dihydropyrimidinone derivatives.
Mostafa AS; Selim KB
Eur J Med Chem; 2018 Aug; 156():304-315. PubMed ID: 30015070
[TBL] [Abstract][Full Text] [Related]
22. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives.
Xue DQ; Zhang XY; Wang CJ; Ma LY; Zhu N; He P; Shao KP; Chen PJ; Gu YF; Zhang XS; Wang CF; Ji CH; Zhang QR; Liu HM
Eur J Med Chem; 2014 Oct; 85():235-44. PubMed ID: 25086915
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumor screening of new 1,7-diphenyl-3-(1,3-disubstituted-1H-pyrazole-4-carbonyl)-[1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones.
Shawali AS; Sherif SM; Darwish MA; El-merzabani MM
Arch Pharm Res; 2010 Jan; 33(1):55-60. PubMed ID: 20191343
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Biological Evaluation of New 1,2,3-Triazole Derivatives of the Chrysin Flavonoid as Anticancer Agents.
Noole V; Krishna T; Godeshala S; Meraji S; Rege K; Reddy CK; Kedika B
Anticancer Agents Med Chem; 2022; 22(1):160-168. PubMed ID: 33719963
[TBL] [Abstract][Full Text] [Related]
29. Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors.
Huang M; Huang Y; Guo J; Yu L; Chang Y; Wang X; Luo J; Huang Y; Tu Z; Lu X; Xu Y; Zhang Z; Zhang Z; Ding K
Eur J Med Chem; 2021 Feb; 211():113023. PubMed ID: 33248853
[TBL] [Abstract][Full Text] [Related]
30. 1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.
Mareddy J; Suresh N; Kumar CG; Kapavarapu R; Jayasree A; Pal S
Bioorg Med Chem Lett; 2017 Feb; 27(3):518-523. PubMed ID: 28011214
[TBL] [Abstract][Full Text] [Related]
31. 1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment toward C6 glioma cell line.
Andrade P; Fraga Dias A; Figueiró F; Torres FC; Kawano DF; Oliveira Battastini AM; Carvalho I; Tomich de Paula da Silva CH; Campos JM
Future Med Chem; 2020 Apr; 12(8):689-708. PubMed ID: 32193951
[No Abstract] [Full Text] [Related]
32. Synthesis of Novel Analogs of Thieno[2,3-
Zhang S; Liu F; Hou X; Cao J; Dai X; Yu J; Huang G
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31640194
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and bioactivities of novel pyrazole and triazole derivatives containing 5-phenyl-2-furan.
Cui ZN; Shi YX; Cui JR; Ling Y; Li BJ; Yang XL
Chem Biol Drug Des; 2012 Jan; 79(1):121-7. PubMed ID: 22023821
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Biological Evaluation of 1,2,3-triazole tethered Pyrazoline and Chalcone Derivatives.
Hussaini SM; Yedla P; Babu KS; Shaik TB; Chityal GK; Kamal A
Chem Biol Drug Des; 2016 Jul; 88(1):97-109. PubMed ID: 26854643
[TBL] [Abstract][Full Text] [Related]
35. Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties.
Bozorov K; Zhao JY; Elmuradov B; Pataer A; Aisa HA
Eur J Med Chem; 2015 Sep; 102():552-73. PubMed ID: 26312434
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and cytotoxic activity evaluation of some novel 1-(3-(aryl-4,5-dihydroisoxazol-5-yl)methyl)-4-trihalomethyl-1H-pyrimidin-2-ones in human cancer cells.
Lobo MM; Viau CM; Dos Santos JM; Bonacorso HG; Martins MA; Amaral SS; Saffi J; Zanatta N
Eur J Med Chem; 2015 Aug; 101():836-42. PubMed ID: 26275603
[TBL] [Abstract][Full Text] [Related]
37. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
Rono CK; Darkwa J; Meyer D; Makhubela BCE
Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
[TBL] [Abstract][Full Text] [Related]
38. One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity.
Holla BS; Rao BS; Sarojini BK; Akberali PM
Eur J Med Chem; 2004 Sep; 39(9):777-83. PubMed ID: 15337290
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis and Anticancer Screening of Novel Benzothiazole-Piperazine-1,2,3-Triazole Hybrids.
Aouad MR; Soliman MA; Alharbi MO; Bardaweel SK; Sahu PK; Ali AA; Messali M; Rezki N; Al-Soud YA
Molecules; 2018 Oct; 23(11):. PubMed ID: 30373247
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]